Steven R. Schow - Concepedia

Author

Steven R. Schow

Also Known As

S R Schow, S. R. SCHOW, S. R. Schow, S. SCHOW, S. Schow, S.R. Schow, STEVEN SCHOW, Steven R Schow, Steven R. Schow, Steven Schow

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Carolina Veterinary Specialists University of California San Diego University of California, San Francisco

About

Steven R. Schow is an author at Carolina Veterinary Specialists specializing in pharmacology, medicine, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	615
2	Natural Sciences	13	15	555
3	Biochemistry	12	13	387
4	Engineering	3	3	71
5	Public Health	1	1	36

Steven R. Schow

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
CVT-313, a Specific and Potent Inhibitor of CDK2 That Prevents Neointimal Proliferation Eric E. Brooks, Nathanael S. Gray, Alison Joly, Journal of Biological Chemistry	1997	141
Milbemycin-avermectin studies. 5. Total synthesis of milbemycin .beta.3 and its C(12) epimer Steven R. Schow, Jonathan D. Bloom, Andrew S. Thompson, Journal of the American Chemical Society Bioorganic ChemistryAltmetric Attention ScorePharmaceutical ChemistryMedicinal ChemistryBiosynthesis	1986	94
Total synthesis of milbemycin .beta.3 Amos B. Smith, Steven R. Schow, Jonathan D. Bloom, Journal of the American Chemical Society BiosynthesisBioorganic ChemistryDonut IconMedicineAltmetric Attention Score	1982	91
A strategy for the total synthesis of jatrophone: synthesis of normethyljatrophone Amos B. Smith, Michael A. Guaciaro, Steven R. Schow, Journal of the American Chemical Society Derivative (Chemistry)Molecular SciencesNatural SciencesDiversity-oriented SynthesisAltmetric Attention Score	1981	81
A Novel Small Molecule That Directly Sensitizes the Insulin Receptor In Vitro and In Vivo Vara Prasad Manchem, Ira D. Goldfine, Ronald A. Kohanski, Diabetes Insulin ReceptorInsulin SignalingMetabolic SyndromeMolecular PharmacologySignaling Pathway	2001	68
Diarylureas are small-molecule inhibitors of insulin-like growth factor I receptor signaling and breast cancer cell growth Karissa Gable, Betty A. Maddux, Cristina Peñaranda, Molecular Cancer Therapeutics	2006	68
Synthesis and activity of 2,6,9-trisubstituted purines Steven R. Schow, Richard L. Mackman, Cheri L. Blum, Bioorganic & Medicinal Chemistry Letters 2,6,9-Trisubstituted PurinesOrganic ChemistryPharmacologySynthetic ChemistryNatural Product Synthesis	1997	63
Utility of the Wittig reaction for the construction of side chains of steroids starting from pregnenolone Steven R. Schow, Trevor C. McMorris The Journal of Organic Chemistry Bioorganic ChemistryAltmetric Attention ScoreSecondary MetaboliteOrganic ChemistryGlucocorticoid	1979	56
N-Acetyl-leucinyl-leucinyl-norleucinal Inhibits Lipopolysaccharide-Induced NF-κB Activation and Prevents TNF and IL-6 Synthesisin Vivo Steven R. Schow, Alison Joly Cellular Immunology InflammationAnti-inflammatoryMedicineImmunologyPrevents Tnf	1997	47
A New Structural Class of Proteasome Inhibitors that Prevent NF-κB Activation Robert T. Lum, S.S. Kerwar, Stephanie Meyer, Biochemical Pharmacology Protease InhibitorsMolecular PharmacologyMedicinal ChemistryProteasome InhibitorsProtein Function	1998	38

Page 1